No Data
No Data
Guosen: The cancellation of export tax rebates on raw materials is expected to benefit domestic sustainable aviation fuel producers.
Due to the cancellation of export tax rebates for industrial-grade blended oil, the enthusiasm of export enterprises will be affected, and domestic SAF and biodiesel production companies are expected to find it easier to obtain raw materials.
Guangzhou Kingmed Diagnostics Group (603882.SH): The company can provide over 4000 testing items to clinical.
gelonhui November 21st, guangzhou kingmed diagnostics group (603882.SH) stated on the interactive platform that, currently, the company can provide over 4000 testing items to clinical settings, and they have established a testing product system covering "full life cycle, all disease fields, and all diagnostic and treatment processes".
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Guangzhou Kingmed Diagnostics Group (603882.SH): will continue to innovate and develop medical AI large models to empower the industry development.
Guangzhou Kingmed Diagnostics Group (603882.SH) stated on the interactive platform that internally, the Kingmed Large Model will serve as the 'Asia Vets Lab Manager,' integrating existing informatization, digitalization, and intelligent applications to innovate internal service and application organization methods in an operationally intelligent manner, embedding AI technology into business processes to achieve cost reduction and efficiency improvement driven by data. Externally, the Kingmed Large Model will act as an 'Asia Vets Medical Consulting Specialist,' making full use of the current large language model's understanding and conversational abilities, combined with Kingmed's own accumulated professional medical knowledge, to provide more caring services for doctors and patients.
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Jinyu Medical: Guangzhou Jinyu Medical Testing Group Co., Ltd. 2024 Third Quarter Report
No Data
No Data